Obstetrics & Gynecology:
Pregnancy‐Related Mortality From Preeclampsia and Eclampsia
MACKAY, ANDREA P. MSPH; BERG, CYNTHIA J. MD, MPH; ATRASH, HANI K. MD, MPH
Office of Analysis, Epidemiology, and Health Promotion, National Center for Health Statistics, Hyattsville, Maryland, and Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Address reprint requests to: Andrea P. MacKay, MSPH, National Center for Health Statistics, 6525 Belcrest Road, Room 790, Hyattsville, MD 20782. E-mail: firstname.lastname@example.org
Received August 17, 2000. Received in revised form November 28, 2000. Accepted December 7, 2000.
Objective: To examine the role of preeclampsia and eclampsia in pregnancy-related mortality.
Methods: We used data from the Centers for Disease Control and Prevention's Pregnancy Mortality Surveillance System to examine pregnancy-related deaths from preeclampsia and eclampsia from 1979 to 1992. The pregnancy-related mortality ratio for preeclampsia-eclampsia was defined as the number of deaths from preeclampsia and eclampsia per 100,000 live births. Case-fatality rates for 1988–1992 were calculated for preeclampsia and eclampsia deaths per 10,000 cases during the delivery hospitalization, using the National Hospital Discharge Survey.
Results: Of 4024 pregnancy-related deaths at 20 weeks' or more gestation in 1979–1992, 790 were due to preeclampsia or eclampsia (1.5 deaths/100,000 live births). Mortality from preeclampsia and eclampsia increased with increasing maternal age. The highest risk of death was at gestational age 20–28 weeks and after the first live birth. Black women were 3.1 times more likely to die from preeclampsia or eclampsia as white women. Women who had received no prenatal care had a higher risk of death from preeclampsia or eclampsia than women who had received any level of prenatal care. The overall preeclampsia-eclampsia case-fatality rate was 6.4 per 10,000 cases at delivery, and was twice as high for black women as for white women.
Conclusion: The continuing racial disparity in mortality from preeclampsia and eclampsia emphasizes the need to identify those differences that contribute to excess mortality among black women, and to develop specific interventions to reduce mortality from preeclampsia and eclampsia among all women.
Pregnancy-induced or aggravated hypertension is an important complication of pregnancy and a leading cause of pregnancy-related death in the United States. The reported incidence of hypertension, including preeclampsia, eclampsia, and superimposed preeclampsia and eclampsia among all pregnant women varies from approximately 3% to 10%.1–3 Hypertension was reported to account for 15% of all antenatal hospitalizations for pregnancy complications.4 Women who develop preeclampsia or eclampsia during pregnancy are at an increased risk of abruptio placentae, acute renal failure, cerebrovascular and cardiovascular complications, and maternal death.3,5
We used data from the Centers for Disease Control and Prevention's (CDC) Pregnancy Mortality Surveillance System to conduct an analysis of pregnancy-related mortality from preeclampsia and eclampsia. We reviewed all reported pregnancy-related deaths in the United States for 1979–1992 to understand trends in pregnancy-related mortality associated with complications of preeclampsia and eclampsia, to identify risk factors for these deaths, and to calculate case-fatality rates.
Materials and Methods
CDC's Division of Reproductive Health, in collaboration with ACOG and state health departments, conducts ongoing surveillance of pregnancy-related deaths. Health departments in the 50 states, the District of Columbia, and New York City provide CDC with copies of death certificates and, when available, matched birth or fetal death certificates for all identified pregnancy-related deaths. The present analysis includes data from 1979 to 1992, the most recent years for which completed data are available.
Deaths were considered pregnancy-related if they occurred during pregnancy or within 1 year of the termination of pregnancy and resulted from complications of pregnancy itself, a chain of events initiated by pregnancy, or aggravation of an unrelated event by the physiologic effects of pregnancy. Information on all pregnancy deaths was reviewed and coded by clinically experienced epidemiologists for cause of death, contributing conditions of death, and outcome of the pregnancy. Deaths were classified using the system designed in collaboration with the CDC/ACOG Maternal Mortality Study Group. Pregnancy-related mortality ratios were defined as the number of pregnancy-related deaths per 100,000 live births. The number of live births was obtained from public-use tapes maintained by CDC's National Center for Health Statistics.
We included deaths from preeclampsia, eclampsia, and chronic hypertension with superimposed preeclampsia or eclampsia in this analysis. Deaths from complications of preexisting, chronic hypertension not aggravated by pregnancy were excluded. We limited the analysis to women with pregnancies at gestational age 20 weeks or greater. We also reviewed deaths from other causes when preeclampsia or eclampsia was a contributory cause of death.
Race-specific mortality for women classified as other than white or black was not analyzed because of small numbers. We examined live birth order as a proxy for parity. Information on live birth order, reported on birth certificates, was available for deaths associated with live births. Information on prenatal care, available for women who died after a live birth, was assessed by using a modification of the Kotelchuck Prenatal Care Utilization Index,6 which combined “intermediate” and “inadequate” care and added a category for women who received no prenatal care. Deaths from states not reporting one or more of the variables needed to calculate the prenatal care utilization index (timing of first prenatal care visit, number of prenatal care visits, and gestational age) were excluded from the analysis of prenatal care for those years during which they did not report (Texas, 1979; New Mexico, 1979–1985; California, 1979–1988).
We defined preeclampsia-eclampsia case-fatality rates as the number of deaths with preeclampsia or eclampsia as the underlying cause of death per 10,000 cases of preeclampsia or eclampsia during the delivery hospitalization. The numerator was the sum of these deaths from the Pregnancy Mortality Surveillance System for 1988–1992. The estimated number of delivery hospitalizations with a diagnosis of preeclampsia or eclampsia for 1988–1992 was obtained from the National Hospital Discharge Survey, an annual multistage probability sample of discharges from nonfederal, short-stay hospitals in the United States. Cases of preeclampsia or eclampsia at delivery were identified using International Classification of Diseases, Ninth Revision codes; we restricted case selection to hospitalizations that indicated a live birth or stillbirth and preeclampsia, eclampsia, or superimposed preeclampsia or eclampsia (ICD-9 codes 642.3–642.7).
For the 14-year study period, we identified 4024 pregnancy-related deaths to women at 20 weeks' or greater gestation; 790 of these deaths (19.6%) were from complications of preeclampsia or eclampsia. The pregnancy-related mortality ratio for deaths from preeclampsia and eclampsia was 1.5 pregnancy-related deaths per 100,000 live births; the overall pregnancy-related mortality ratio for deaths occurring at 20 weeks' or greater gestation was 7.5/100,000. The most frequent causes of pregnancy-related death were embolism, hemorrhage, and preeclampsia or eclampsia (Table 1).
Approximately half (51%) of preeclampsia-eclampsia deaths were associated with preeclampsia, the remainder with eclampsia. The largest percentage of preeclampsia and eclampsia deaths was attributed to cerebrovascular complications, primarily cerebrovascular hemorrhage (Table 2). Renal or hepatic failure was also frequently listed as the cause of death. Disseminated intravascular coagulation was a contributing condition in 15% of hypertension deaths.
Preeclampsia or eclampsia was a contributing condition of death in 4.5% of pregnancy-related deaths because of other causes of death (185 deaths). Approximately 11% of anesthesia deaths, 7% of cardiomyopathy deaths, and 10% of deaths from abruptio placentae were complicated by preeclampsia or eclampsia.
The risk of death from preeclampsia or eclampsia was higher for older women than for younger women (Table 3). Black women were at a greater risk of such deaths than white women. The disparity in the risk of death between white and black women was greatest among women aged 30 to 34 years, with black women having more than four times the risk of white women. Among all women, the risk of death from preeclampsia or eclampsia was highest after the first and fifth or higher live birth (Table 3); however, more than half of such deaths occurred after the first live birth and less than 8% after the fifth or higher. Although 47% of deaths from preeclampsia or eclampsia occurred during or after the 37th week of gestation, the greatest risk of death was among women with pregnancies at 28 or fewer weeks' gestation (Table 3).
Women who had received no prenatal care had a higher risk of death from preeclampsia or eclampsia than women who had received any prenatal care (Table 3). Among white women the risk of death associated with no prenatal care was 12 times that for adequate care; among black women the risk associated with no care was approximately four times that of adequate care.
The case-fatality rate for deaths from preeclampsia or eclampsia was 6.4 deaths per 10,000 cases at delivery (Table 4); the case-fatality rate for deaths associated with eclampsia (71.6) was strikingly higher than for deaths associated with preeclampsia (3.4). The risk of death for women 35 years and older was more than three times that of women 24 years or younger. Case-fatality rates for black women were twice those for white women; the prevalence of preeclampsia or eclampsia at the delivery hospitalization among black women was 1.4 times that of white women.
The results of this analysis are consistent with findings from previous studies of pregnancy-related mortality in which complications of hypertension were found to be the third leading cause of pregnancy-related death, after hemorrhage and embolism.7 The age-specific mortality ratios for preeclampsia and eclampsia reflect the trend observed in other studies—slightly increased risk for younger women (under 20 years) and markedly increased for older women, especially older black women.7 Hansen8 reported that hypertension is more common and carries an increased risk of death among older pregnant women, contributing to the several-fold increase in overall pregnancy mortality for older women compared with younger women.
Although most women in this analysis died after their first live birth, mortality from preeclampsia or eclampsia is not limited to first pregnancies; 40% of the women who died had a previous live birth. Other studies have found that women with a history of hypertension in a prior pregnancy or with a family history of chronic hypertension are at a greater risk of developing hypertension during pregnancy.9 We could not evaluate the role of these risks, as past medical history and family medical history were not available. Further, we could not evaluate the potentially confounding effects of age and birth order because of relatively small numbers.
The racial disparity in overall pregnancy-related mortality is also seen in hypertension-specific mortality.10–12 The combination of a higher prevalence of preeclampsia and eclampsia among black women and higher case-fatality rates contributed to pregnancy-related mortality rates because of preeclampsia and eclampsia for black women more than three times that of white women.
Women who received no prenatal care were more than seven times as likely to die from complications of preeclampsia or eclampsia as women receiving any prenatal care. Although black and white women who received prenatal care had a lower risk of death than women who received no prenatal care, there was a far greater reduction in the risk of death for white women receiving adequate prenatal care than for black women. This finding may reflect the quality of prenatal care, which is not measured by the Prenatal Care Utilization Index, or may be related to other factors not measurable from the data available. Whereas several studies have suggested that the content of prenatal care may differ for black women and white women,13,14 another study reported that black women receiving prenatal care reported significantly fewer prenatal visits than white women during the 8th and 9th months of pregnancy, those months when preeclampsia onset is most common.15
Although a rare event, onset of severe preeclampsia in the second trimester is associated with a higher risk of maternal and fetal morbidity and mortality.16 We found a dramatic increase in the risk of death for women at 20–32 weeks' gestation compared with women at 36–40 weeks or more. The mortality ratios for black and white women during the second trimester were similar; however, for women at 37–40 weeks' gestation, we found a threefold difference in the risk of death for black women compared with white women. This finding may be a further indication of a disparity in health status and access to and quality of prenatal care.
Cerebral hemorrhage has been reported in as many as 60% of all deaths from eclampsia.17 Seven percent of deaths in this study were attributed to hemolysis, elevated liver enzymes, and low platelet count syndrome, a variant of severe hypertension that results in multiorgan failure, which has cited mortality rates ranging from 2% to 24% of cases.18 Preeclampsia and eclampsia have been associated with an increased risk of abruptio placentae,5 disseminated intravascular coagulation, and acute renal failure.17 Abruptio placentae complicated 4% of the pregnancies of women who died of preeclampsia or eclampsia, more than four times the incidence of abruption at the delivery hospitalization for all women.1
The limitations of this analysis should be considered. Pregnancy-related mortality ratios are underestimated; despite improved ascertainment methods initiated over the study period, more than half of pregnancy-related deaths are not identified through routine surveillance methods.19,20 Preeclampsia and eclampsia are multisystem disorders of unknown etiology; the complex nature of complications may lead to misclassification of the underlying cause of death. Cause of death information was obtained from death certificates; therefore, we could not standardize our definitions. For some women, information about preexisting hypertension or chronic renal disease may not have been provided. Estimates from the National Hospital Discharge Survey are subject to errors associated with the use of medical records, including incorrect diagnoses or coder errors.
Deaths from preeclampsia and eclampsia are often preventable.21 Prenatal care, early detection, and careful monitoring and treatment during pregnancy are essential to prevent serious complications.3 It is important for clinicians to identify women with preexisting hypertensive disorders, a prior history of hypertension, or a family history of hypertension, and to educate women about the early warning signs of preeclampsia. The continuing racial disparity in preeclampsia and eclampsia mortality ratios emphasizes the need to identify those differences that contribute to excess mortality among black women, and to develop specific interventions to reduce mortality from preeclampsia and eclampsia among all women.
1. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of hypertension in the United States, 1979–1986. Am J Obstet Gynecol 1990;163:460–5.
2. Burrows RF, Burrows EA. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1995; 173:929–35.
3. Cunningham FG, MacDonald PC, Gant NF, McDonald PC, Leveno KJ, Gilstrap LC, et al. Williams obstetrics. 20th ed. Norwalk, Connecticut: Appleton & Lange, 1997.
4. Scott CL, Chavez GF, Atrash HK, Taylor DJ, Shah RS, Rowley D. Hospitalizations for severe complications of pregnancy, 1987–1992. Obstet Gynecol 1997;90:225–9.
5. Abdella TN, Sibai BM, Hays JM, Anderson GD. Relationship of hypertensive disease to abruptio placentae. Obstet Gynecol 1984; 63:365–70.
6. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed adequacy of prenatal care utilization index. Am J Public Health 1994;84:1414–20.
7. Koonin LM, MacKay AP, Berg CJ, Atrash HK, Smith JC. Pregnancy-related mortality surveillance—United States, 1987–1990. MMWR Morb Mortal Wkly Rep CDC Surveill Summ 1997;46(4):17–36.
8. Hansen JP. Older maternal age and pregnancy outcome: A review of the literature. Obstet Gynecol Surv 1986;41:726–42.
9. Sibai BM, El-Nazur A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women; subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986;155:1011–6.
10. Centers for Disease Control. Differences in maternal mortality among black and white women—United States, 1990. MMWR Morb Mortal Wkly Rep 1995;44:6–14.
11. Gillum RF. Epidemiology of hypertension in African American women. Am Heart J 1996;131:385–95.
12. Samadi AR, Mayberry RM, Zaidi AA, Pleasant JC, McGhee N Jr, Rice RJ. Maternal hypertension and associated complications among African-American and other women in the United States. Obstet Gynecol 1996;87:557–63.
13. Kogan MD, Kotelchuck M, Alexander GR, Johnson WE. Racial disparities in reported prenatal care advice from health care providers. Am J Public Health 1994;84:82–8.
14. Brett KM, Schoendorf KC, Kiely JL. Differences between black and white women in the use of prenatal care technologies. Am J Obstet Gynecol 1994;170:41–6.
15. Kogan MD, Kotelchuck M, Johnson S. Racial differences in late prenatal care visits. J Perinatol 1993;13:14–21.
16. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408–12.
17. Beck DW, Menezes MB. Intracerebral hemorrhage in a patient with eclampsia. JAMA 1981;246:1442–3.
18. Sibai BM, Taslimi MM, El-Nazur A, Armon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501–9.
19. Centers for Disease Control. Enhanced maternal mortality surveillance—North Carolina, 1988 and 1989. MMWR Morb Mortal Wkly Rep 1991;40:469–71.
20. Centers for Disease Control. Pregnancy-related mortality—Georgia, 1990–1992. MMWR Morb Mortal Wkly Rep 1995;44:93–6.
21. Sachs BP, Brown DA, Driscoll SG, Schulman E, Acker D, Ransil BJ, et al. Maternal mortality in Massachusetts: Trends and prevention. N Engl J Med 1987;316:667–72.
This article has been cited 125 time(s).
Geburtshilfe Und Frauenheilkunde
Obstetrics. Prenatal Care in Reconstruction: From Head to Toe?
Geburtshilfe Und Frauenheilkunde, 73(4):
Journal of Maternal-Fetal & Neonatal MedicineComparison of clinical and laboratory findings in early- and late-onset preeclampsiaJournal of Maternal-Fetal & Neonatal Medicine
Journal of Maternal-Fetal & Neonatal MedicineThe severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restrictionJournal of Maternal-Fetal & Neonatal Medicine
Human Reproduction UpdatePlacental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsiaHuman Reproduction Update
LancetMaternal and child undernutrition and overweight in low-income and middle-income countriesLancet
Archives of Gynecology and ObstetricsIs serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?Archives of Gynecology and Obstetrics
HypertensionRedefining Preeclampsia Using Placenta-Derived BiomarkersHypertension
Molecular and Cellular EndocrinologyHypomethylation of the LEP gene in placenta and elevated maternal leptin concentration in early onset pre-eclampsiaMolecular and Cellular Endocrinology
Journal of Maternal-Fetal & Neonatal MedicineMaternal, fetal and perinatal characteristics of preeclampsia cases with and without abnormalities in uterine artery Doppler indexesJournal of Maternal-Fetal & Neonatal Medicine
American Family Physician
Diagnosis and management of Preeclampsia
American Family Physician, 70():
American Journal of Obstetrics and GynecologyFactors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosusAmerican Journal of Obstetrics and Gynecology
Clinical and Applied Thrombosis-Hemostasis
Coagulation and fibrinolysis in preeclampsia and neonates
Clinical and Applied Thrombosis-Hemostasis, 11(4):
HypertensionRecombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsiaHypertension
Fetal Diagnosis and TherapyScreening for Placental Insufficiency by Transvaginal Uterine Artery Doppler at 22-24 Weeks of GestationFetal Diagnosis and Therapy
Bjog-An International Journal of Obstetrics and GynaecologyToll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre-eclampsiaBjog-An International Journal of Obstetrics and Gynaecology
Journal of Epidemiology
Lifestyles and pre-eclampsia with special attention to cigarette smoking
Journal of Epidemiology, 13(2):
European Journal of Obstetrics Gynecology and Reproductive BiologySocial deprivation and poor access to care as risk factors for severe pre-eclampsiaEuropean Journal of Obstetrics Gynecology and Reproductive Biology
Australian & New Zealand Journal of Obstetrics & Gynaecology
Hypertension during pregnancy in South Australia, Part 1: Pregnancy outcomes
Australian & New Zealand Journal of Obstetrics & Gynaecology, 44(5):
Journal of Maternal-Fetal & Neonatal MedicineCharacteristics of preeclampsia- and eclampsia-related maternal death in rural HaitiJournal of Maternal-Fetal & Neonatal Medicine
International Journal of Gynecology & ObstetricsPregnancy outcomes of women with eclampsia in Gombe, NigeriaInternational Journal of Gynecology & Obstetrics
International Journal of Gynecology & ObstetricsMaternal deaths due to eclampsia and HELLP syndromeInternational Journal of Gynecology & Obstetrics
Hypertension ResearchAdipocytokines and endothelial function in preeclamptic womenHypertension Research
Acta Obstetricia Et Gynecologica ScandinavicaFamily history of hypertension as an important risk factor for the development of severe preeclampsiaActa Obstetricia Et Gynecologica Scandinavica
American Journal of Obstetrics and GynecologyDifferential expression of TcR-CD3 zeta as evidence for altered immunoregulation in preeclamptic versus normotensive womenAmerican Journal of Obstetrics and Gynecology
Cellular and Molecular BiologyENDOGENOUS Na/K-ATPase INHIBITORS IN PATIENTS WITH PREECLAMPSIACellular and Molecular Biology
Nutrition ReviewsVitamin D for the prevention of preeclampsia? A hypothesisNutrition Reviews
Increased uterine arterial pressure and contractility of perfused swine uterus after treatment with serum from pre-eclamptic women and endothelin-I
Clinical Science, 109(2):
Canadian Medical Association JournalHeadache and seizure on postpartum day 5: late postpartum eclampsiaCanadian Medical Association Journal
Seminars in PerinatologyThe Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology
Journal of Nephrology
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up
Journal of Nephrology, 21(5):
Current Vascular Pharmacology
Potential Cell Signalling Mechanisms Involved in Differential Placental Angiogenesis in Mild and Severe Pre-Eclampsia
Current Vascular Pharmacology, 7(4):
Environmental Health PerspectivesPesticide Exposure and Hypertensive Disorders during PregnancyEnvironmental Health Perspectives
Journal of Ultrasound in Medicine
Should Bilateral Uterine Artery Notching Be Used in the Risk Assessment for Preeclampsia, Small-for-Gestational-Age, and Gestational Hypertension?
Journal of Ultrasound in Medicine, 29(7):
Geburtshilfe Und FrauenheilkundeManagement of preeclampsia remote from termGeburtshilfe Und Frauenheilkunde
Journal of Obstetrics and Gynaecology Research
Neutrophil apoptosis in preeclampsia, do steroids confound the relationship?
Journal of Obstetrics and Gynaecology Research, 30(5):
PlacentaMicroarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsiaPlacenta
Best Practice & Research in Clinical Obstetrics & GynaecologyMaternal mortality in the United StatesBest Practice & Research in Clinical Obstetrics & Gynaecology
Annual Review of Pathology-Mechanisms of DiseasePathogenesis of PreeclampsiaAnnual Review of Pathology-Mechanisms of Disease
American Journal of EpidemiologyRisk of gestational hypertension in relation to folic acid supplementation during pregnancyAmerican Journal of Epidemiology
Gynecologic and Obstetric InvestigationProteomic analysis of proteins differentially expressed in preeclamptic trophoblastsGynecologic and Obstetric Investigation
American Journal of Obstetrics and GynecologyDoes maternal race or ethnicity affect the expression of severe preeclampsia?American Journal of Obstetrics and Gynecology
International Journal of Gynecology & ObstetricsPlacental growth factor in the cerebrospinal fluid of women with preeclampsiaInternational Journal of Gynecology & Obstetrics
American Journal of Obstetrics and GynecologyIdentification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factorAmerican Journal of Obstetrics and Gynecology
Journal of Clinical Endocrinology & MetabolismMaternal vitamin D deficiency increases the risk of preeclampsiaJournal of Clinical Endocrinology & Metabolism
American Journal of Obstetrics and GynecologyPrediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasmaAmerican Journal of Obstetrics and Gynecology
Womens Health IssuesThe Denial of Abortion Care Information, Referrals, and Services Undermines Quality Care for Us WomenWomens Health Issues
American Journal of Emergency MedicineA current concept of eclampsiaAmerican Journal of Emergency Medicine
Obstetrics and GynecologyPregnancy-related mortality among women aged 35 years and older, United States, 1991-1997Obstetrics and Gynecology
Journal of Clinical Endocrinology & MetabolismThe intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurityJournal of Clinical Endocrinology & Metabolism
Acta Obstetricia Et Gynecologica Scandinavica
High-density lipoprotein and homocysteine levels correlate inversely in preeclamptic women in northern Nigeria
Acta Obstetricia Et Gynecologica Scandinavica, 83(6):
Seminars in PerinatologyPredicting Adverse Outcomes in Women with Severe Pre-eclampsiaSeminars in Perinatology
Health EconomicsMaternal health: does prenatal care make a difference?Health Economics
Journal of Maternal-Fetal & Neonatal MedicineMaternal mortality rates in the last eight years: A university hospital-based study from TurkeyJournal of Maternal-Fetal & Neonatal Medicine
Biology of ReproductionSevere feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsiaBiology of Reproduction
American Journal of Emergency MedicineDiagnosis and management of labile blood pressure during acute cerebrovascular accidents and other hypertensive crisesAmerican Journal of Emergency Medicine
Neurologic ClinicsStroke in Women: Risk and Prevention Throughout the LifespanNeurologic Clinics
Prenatal DiagnosisEarly onset preeclampsia and second trimester serum markersPrenatal Diagnosis
PlacentaDynamics of placental ghrelin production and its receptor expression in a Dahl salt-sensitive rat model of intrauterine growth restrictionPlacenta
HypertensionCerebral blood flow autoregulation and edema formation during pregnancy in anesthetized ratsHypertension
Journal of Perinatal MedicineAdiponectin in severe preeclampsiaJournal of Perinatal Medicine
Maternal and Child Health Journal
Racial disparity in infant and maternal mortality: Confluence of infection, and microvascular dysfunction
Maternal and Child Health Journal, 8(2):
American Journal of Obstetrics and GynecologyUrinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsiaAmerican Journal of Obstetrics and Gynecology
Bjog-An International Journal of Obstetrics and GynaecologyRelationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancyBjog-An International Journal of Obstetrics and Gynaecology
Hypertension in PregnancyA comparison of walking versus stretching exercises to reduce the incidence of preeclampsia: A randomized clinical trialHypertension in Pregnancy
Hypertension in PregnancyIn Vitro Fertilization is Associated with an Increased Risk for PreeclampsiaHypertension in Pregnancy
PlacentaNovel Splice Variants of sFlt1 are Upregulated in PreeclampsiaPlacenta
Journal of Reproductive ImmunologyThe link between insulin resistance and preeclampsia: new perspectivesJournal of Reproductive Immunology
Thrombosis ResearchChanges of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancyThrombosis Research
Hypertension in PregnancySubclassification of preeclampsiaHypertension in Pregnancy
Prenatal DiagnosisGene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screeningPrenatal Diagnosis
Ultrasound in Obstetrics & GynecologyRandomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestationUltrasound in Obstetrics & Gynecology
International Journal of Obstetric AnesthesiaMaternal and fetal outcome of anaesthesia for caesarean delivery in preeclampsia/eclampsia in Enugu, Nigeria: a retrospective observational studyInternational Journal of Obstetric Anesthesia
Paediatric and Perinatal Epidemiology
Safe motherhood in Jamaica: from slavery to self-determination
Paediatric and Perinatal Epidemiology, 19(4):
Clinical ChemistryProtein: Creatinine ratio in random urine samples is a reliable marker of increased 24-hour protein excretion in hospitalized women with hypertensive disorders of pregnancyClinical Chemistry
Acta Bioquimica Clinica Latinoamericana
Evaluation of maternal-fetal risks and reference values in pregnancy
Acta Bioquimica Clinica Latinoamericana, 41(4):
Prenatal DiagnosisGene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsiaPrenatal Diagnosis
Journal De Gynecologie Obstetrique Et Biologie De La ReproductionLatest developments: Management and treatment of preeclampsiaJournal De Gynecologie Obstetrique Et Biologie De La Reproduction
Journal of Maternal-Fetal & Neonatal MedicineA prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsiaJournal of Maternal-Fetal & Neonatal Medicine
Australian & New Zealand Journal of Obstetrics & Gynaecology
Risk factors for hypertension during pregnancy in South Australia
Australian & New Zealand Journal of Obstetrics & Gynaecology, 43(6):
Proceedings of the Xvii Meeting International Society of Haematology (European and African Division)
Can the free forms of TFPI and free protein S be the hallmark of the coagulopathy of pre-eclampsia?
Proceedings of the Xvii Meeting International Society of Haematology (European and African Division), ():
Thrombosis and HaemostasisEfficacy of AT in pre-eclampsia: a case-control prospective trialThrombosis and Haemostasis
International Journal of Gynecology & ObstetricsHypertensive disorders of pregnancyInternational Journal of Gynecology & Obstetrics
Hypertension in PregnancyThe correlation between renal function and systolic or diastolic blood pressure in severe preeclamptic womenHypertension in Pregnancy
Geburtshilfe Und FrauenheilkundeAsymmetric dimethylarginine (ADMA): an endogenous inhibitor of NO synthase - also a risk marker for preeclampsia?Geburtshilfe Und Frauenheilkunde
Hypertension in PregnancySerum Inhibin A Level in Preeclampsia and Normotensive PregnancyHypertension in Pregnancy
Reproductive Biology and EndocrinologyMouse models for preeclampsia: disruption of redox-regulated signalingReproductive Biology and Endocrinology
Bjog-An International Journal of Obstetrics and GynaecologyThe role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratioBjog-An International Journal of Obstetrics and Gynaecology
Severe pathology associated with pre-eclampsia: Complications almost forgotten
Clinics in Laboratory MedicineAutoimmune disease as a cause of reproductive failureClinics in Laboratory Medicine
Annals of Saudi Medicine
Partial recovery of the visual field scotoma upon early retinal photocoagulation and the medical therapy in a preeclamptic patient
Annals of Saudi Medicine, 24(6):
Clinical Chemistry and Laboratory MedicineConcentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional statusClinical Chemistry and Laboratory Medicine
Journal of Womens Health
Changes in health status experienced by women with gestational diabetes and pregnancy-induced hypertensive disorders
Journal of Womens Health, 14(8):
American Journal of PsychiatrySelective Serotonin Reuptake Inhibitor Use and Risk of Gestational HypertensionAmerican Journal of Psychiatry
Prenatal DiagnosisThe relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsiaPrenatal Diagnosis
American Journal of Obstetrics and GynecologyImplications of vitamin D deficiency in pregnancy and lactationAmerican Journal of Obstetrics and Gynecology
Family Planning Perspectives
Preeclampisa and eclampsia, while often preventable, are among top causes of pregnancy-related deaths
Family Planning Perspectives, 33(4):
Bjog-An International Journal of Obstetrics and GynaecologyLevels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsiaBjog-An International Journal of Obstetrics and Gynaecology
Regional anaesthesia in pre-eclampsia advantages and disadvantages
Clinical Drug Investigation
Depression during pregnancy - Overview of clinical factors
Clinical Drug Investigation, 24(3):
Critical Care ClinicsPregnancy-associated severe liver dysfunctionCritical Care Clinics
American Journal of Obstetrics and GynecologySerum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsiaAmerican Journal of Obstetrics and Gynecology
Frontiers in Bioscience
Matrix metalloproteinases: control of vascular function and their potential role in preeclampsia
Frontiers in Bioscience, 12():
Turkish Journal of Medical Sciences
Placental heat shock protein 70 overexpression confers resistance against oxidative stress in preeclampsia
Turkish Journal of Medical Sciences, 38(1):
Advances in Chronic Kidney DiseaseNew Developments in the Pathogenesis of PreeclampsiaAdvances in Chronic Kidney Disease
Hypertension ResearchIncreased oxygen free radical production during pregnancy may impair vascular reactivity in preeclamptic womenHypertension Research
Reproduction in Domestic AnimalsWho Let the Dogs In: A Canine Trophoblast Invasion Model for Pre-eclampsiaReproduction in Domestic Animals
American Journal of Obstetrics and GynecologyPerformance of a first-trimester screening of preeclampsia in a routine care low-risk settingAmerican Journal of Obstetrics and Gynecology
Prenatal DiagnosisCan detection of late-onset PE at triage by sflt-1 or PlGF be improved by the use of additional biomarkers?Prenatal Diagnosis
HypertensionFolic Acid Supplementation During Early Pregnancy and the Risk of Gestational Hypertension and PreeclampsiaHypertension
International Journal of Gynecology & ObstetricsErrors in the treatment of hypertensive disorders of pregnancy and their impact on maternal mortalityInternational Journal of Gynecology & Obstetrics
Circulation-Cardiovascular ImagingSubclinical Left Ventricular Dysfunction in Preeclamptic Women With Preserved Left Ventricular Ejection Fraction A 2D Speckle-Tracking Imaging StudyCirculation-Cardiovascular Imaging
Obstetrical & Gynecological SurveyLate Postpartum Eclampsia: Examples and ReviewObstetrical & Gynecological Survey
Clinical Obstetrics and GynecologyEclampsia: Morbidity, Mortality, and ManagementClinical Obstetrics and Gynecology
Clinical Obstetrics and GynecologyAcute Complications of PreeclampsiaClinical Obstetrics and Gynecology
Current Opinion in Obstetrics and GynecologyHypertensive diseases and eclampsiaCurrent Opinion in Obstetrics and Gynecology
Obstetrics & GynecologyDiagnosis, Prevention, and Management of EclampsiaObstetrics & Gynecology
Obstetrics & GynecologyIncidence and Risk Factors for Stroke in Pregnancy and the PuerperiumObstetrics & Gynecology
Journal of HypertensionLow socioeconomic status is a risk factor for preeclampsia: the Generation R StudyJournal of Hypertension
Obstetrical & Gynecological SurveyVitamin D May Be a Link to Black-White Disparities in Adverse Birth OutcomesObstetrical & Gynecological Survey
Obstetrical & Gynecological SurveyPreeclampsia. Part 1: Clinical and Pathophysiologic ConsiderationsObstetrical & Gynecological Survey
Southern Medical JournalPreeclampsia and Eclampsia RevisitedSouthern Medical Journal
© 2001 The American College of Obstetricians and Gynecologists